KAT8: A Promising Biomarker for the Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.

Key Points

• The aim is to evaluate KAT8 as a biomarker for predicting outcomes in hepatitis B virus-related acute-on-chronic liver failure.
• Assessment of KAT8 levels in patients with HBV-ACLF
• Statistical analysis to correlate KAT8 with patient prognosis
• Finding a significant relationship between KAT8 levels and patient outcomes
• Suggesting that higher KAT8 levels may indicate poorer prognosis in HBV-ACLF patients